A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation
暂无分享,去创建一个
S. Kambhampati | A. Lichtenstein | Y. Efebera | T. Hayes | A. Mohiuddin | A. Houranieh | P. Mehta | M. Rose | S. Yellapragada | S. Lee | C. Behler | C. Klein | T. Grady | A. Zimelman | Nikhil C. Munshi | Rao H. Prabhala | A. Han | Saulius K. Girnius | Garson D. Roodman